E. coli- challenged vs. unchallenged control cells | |
---|---|
Canonical pathway (Genes involved in pathway) | p -value |
Granulocyte Adhesion and Diapedesis(CXCL3,IL1A,VCAM1,ICAM1,CCL2,CLDN1,CXCL1,CXCL2,IL1RAP,CXCL6,ITGB3) | 8.52E-11 |
Interferon Signaling(IFIT3,IFIT1,JAK2,IFNAR2,IFNAR1,IRF1) | 4.11E-09 |
Agranulocyte Adhesion and Diapedesis(CXCL3,IL1A,VCAM1,ICAM1,CCL2,CLDN1,CXCL1,CXCL2,CXCL6) | 4.92E-08 |
Hepatic Fibrosis/Hepatic Stellate Cell Activation(CXCL3,IL1A,VCAM1,ICAM1,CCL2,IFNAR2,IL1RAP,IFNAR1) | 8.20E-08 |
Role of IL-17A in arthritis(CXCL3,NFKBIA,CCL2,CXCL1,CXCL6) | 2.43E-06 |
S. aureus- challenged vs. unchallenged control cells | |
Canonical pathway (Genes involved in pathway) | p -value |
Bupropion Degradation | 3.44E-06 |
Acetone Degradation I (to Methylglyoxal) | 3.86E-06 |
Estrogen Biosynthesis | 1.11E-05 |
Nicotine Degradation III | 2.87E-05 |
Melatonin Degradation I(CYP1A1,CYP3A4,CYP1B1 are involved in all five canonical pathways) | 3.39E-05 |